Page 2 - Roche Diagnostics News Today

Wei Zhou and co-workers explore the impact of fresh Versus frozen embryo transfer on the metabolic profiles of children in China.

Press release - AMA Research & Media LLP - Antibody Discovery Market Demand Will Increase to 2030 Evaluated By Global Top Players Like BASF SE., Bruker, Alcami - published on openPR.com

Press release - DataM Intelligence - Monoclonal Antibody Therapeutics Market Size Analysis and Regional Analysis Forecast to (2024-2031) F. Hoffmann-La Roche, Novartis AG. - published on openPR.com

University of Dundee researchers hope their findings could lead to benefits for patients around the world.

This is an opportune time to reflect on the strides made in healthcare across the continent.

Roche announces that its Tina-quant lipoprotein Lp RxDx test has been designated a breakthrough device by the U.S. FDA to identify patients likely to benefit from an innovative Lp-lowering therapy...

The deal is the second acquisition for CG Life this year, following the addition of Toolhouse in March.

Press release - ABNewswire - Antibody Therapeutics Market Worth $479.0 Billion | MarketsandMarkets - published on openPR.com

In 2014, the cobas human papillomavirus test was approved by the FDA for first-line, primary screening in women aged 25 years and older.

The new Scottish Brain Sciences (SBS) laboratory at the University of St Andrews Eden Campus innovation hub and multinational healthcare company Roche Diagnostics, are collaborating in a study that will bring the first blood tests to Scotland for the detection of Alzheimer’s disease in its early stages. Click to read more...